Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

CTLT Price Correlated With Financials For Catalent

Free historical financial statements for Catalent Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 31 quarters since 2014. Compare with CTLT stock chart to see long term trends.

CTLT Stock Compared to Quarterly

CTLT Income Statement

Revenue, Net:1273000000
Revenue Per Share:7.1033
Cost of Goods & Services Sold:850000000
Gross Profit:423000000
Selling, General & Admin Expense:207000000
Research & Development Expense:6000000
Operating Income:211000000
Income Taxes:35000000
Net Income:141000000
Earnings Per Share, Basic:0.78
Shares Outstanding, Basic Avg:179213237

CTLT Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:99000000
Change in Accounts Receiveable:null
Net Cash from Operations:null
Net Cash from Operations Per Share:null
Net Cash from Financing Activities:null
Property, Plant & Equipment Purchases:null
Purchases of Businesses, Net of Cash:null
Net Cash from Investing Activities:null
Net Change in Cash & Equivalents:null

CTLT Balance Sheet

Cash and Cash Equivalents:786000000
Accounts Receivable, Net:932000000
Inventories:676000000
Total Current Assets:3025000000
Property, Plant & Equipment, Net:2820000000
Total Assets:10322000000
Accounts Payable:401000000
Total Short-Term Liabilities:1046000000
Total Liabilities:5690000000

Data imported from Catalent Inc SEC filings. Check original filings before making any investment decision.